Weitere Artikel dieser Ausgabe durch Wischen aufrufen
The authors would like to gratefully acknowledge Editor-in-Chief Mike Peng and the anonymous reviewers for their excellent guidance and encouragement. We would also like to thank the Malaysian Biotech Corporation, Bionexus, and the Malaysian Life Sciences Fund for their generous support of this research study, as well as the participants who provided their insights. We are thankful for the efforts of our research assistants, Rebecca Bednarek and Melvyn Loh; and grateful to Rob Wiltbank and Stephen Cummings for their helpful feedback on earlier versions. All views and errors are ours.
In this study, we use both resource-based and institution-based theories to examine potential sources of competitive advantage in the relatively new and rapidly growing biotechnology sector. We then use those theories as the basis for a multimethod study to assess the priorities, capabilities, and competitiveness of the emerging biotechnology industry in Malaysia. Multifunctional experts from a biotechnology industry organization in Malaysia identified the use of biotechnology for agriculture and biofuels as key country priorities, with access to funding and talent cited as key capabilities required for successful sector development. The gap between capabilities required and strategic priorities provides a “to do” list for industry development, with government institutions playing a central role in accelerating technology development and providing the capital flows necessary to bridge this gap. Implications include the need for public–private sector collaboration to enable biotech firms to efficiently obtain international investment and alliances to ensure sustainability, as well as to develop bold and creative approaches for developing and recruiting talent both at home and abroad.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Ahn, M., & Meeks, M. 2007. Building a conducive environment for life science based entrepreneurship and industry clusters. Journal of Commercial Biotechnology, 14: 20–30. CrossRef
Ahn, M., Davenport, S., Meeks, M., & Bednarek, R. 2009. Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms. Journal of Commercial Biotechnology. doi: 10.1057/jcb.2009.8.
Andersson, T., Serger, S., Sorvik, J., & Hansson, E. W. 2004. The cluster policy whitebook. Sweden: International Organization for Knowledge Economy and Enterprise Development.
Andriesse, E., & van Westen, G. 2009. Unsustainable varieties of capitalism along the Thailand–Malaysia border? The role of institutional complementarities in regional development. Asia Pacific Journal of Management, 26. doi: 10.1007/s10490-008-9107-2.
Azoulay, P., Michigan, R., & Sampat, B. 2007. The anatomy of medical school patenting. New England Journal of Medicine, 357: 2049–56. CrossRef
Barney, J. B. 1991. Firm resources and sustained competitive advantage. Journal of Management, 17(1): 99–120. CrossRef
Barney, J. B. 2001. Resource-based theories of competitive advantage: A ten-year retrospective on the resource-based view. Journal of Management, 27(6): 643–650. CrossRef
Baum, J. A. C., & Silverman, B. S. 2004. Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance in biotechnology startups. Journal of Business Venturing, 19: 411–436. CrossRef
BIO (Biotechnology Industry Organization). 2006. BIO 2005–2006: Guide to biotechnology. http://www.bio.org, Accessed May 5, 2007.
BIO (Biotechnology Industry Organization). 2007. BIO 2006–2007: Guide to biotechnology. http://www.bio.org, Accessed Apr. 20, 2008.
Boehm, T. & Schuehsler, H. 2003. Where do biotechnology venture capitalists go from here?. http://www.thebiotechclub.org, Accessed Oct. 3, 2007.
Burrill & Co. 2007. Life sciences: A global transformation. San Francisco: Burrill Life Sciences Venture Capital Group.
Carney, M., Gedajlovic, E., & Yang, X. 2009. Varieties of Asian capitalism. Asia Pacific Journal of Management, 26. doi: 10.1007/s10490-009-9139-2.
Casper, S. 2007. How do technology clusters emerge and become sustainable? Social network formation and inter-firm mobility within the San Diego biotechnology cluster. Research Policy, 36(4): 438–455. CrossRef
CHI (California Healthcare Institute). 2006. California’s biomedical industry 2006 report. http://www.chi.org, Accessed Dec. 5, 2007.
Deeds, D. I., DeCarolis, D., & Coombs, J. 1991. Dynamic capabilities and new product development in high technology ventures: An empirical analysis of biotechnology firms. Journal of Business Venturing, 15: 211–229. CrossRef
DeFillipi, R., & Arthur, M. 1998. Paradox in project-based enterprise: The case of film making. California Management Review, 40(2): 125–139.
Dodgson, M. 2009. Asia’s national innovation systems: Institutional adaptability and rigidity in the face of global innovation challenges. Asia Pacific Journal of Management, 26. doi: 10.1007/s10490-008-9105-4.
Eisenhardt, K. M., & Graebner, M. E. 2007. Theory building from cases: Opportunities and challenges. Academy of Management Journal, 50(1): 25–32.
EYGM (Ernst & Young). 2008. Strategic business risk: Biotechnology 2008. http://www.ey.com, Accessed Jun. 1, 2008.
Feldman, M. 2003. The locational dynamics of the US biotech industry: Knowledge externalities and the anchor hypothesis. Industry & Innovation, 10: 311–328. CrossRef
Frost & Sullivan. 2001. Southeast Asia: Gearing up for the bio-economy wave. http://www.frost.com, Accessed Dec. 15, 2008.
Furman, J. L., Porter, M. E., & Stern, S. 2002. The determinants of national innovative capacity. Research Policy, 31(6): 899–933. CrossRef
Goetz, S., & Morgan, S. 1995. State-level localization determinants of biotechnology firms. Economic Development Quarterly, 9: 174–184. CrossRef
Iammarino, S., & McCann, P. 2006. The structure and evolution of industrial clusters: Transactions, technology and knowledge spillovers. Research Policy, 35(7): 1018–1036. CrossRef
Jick, T. D. 1979. Mixing qualitative and quantitative methods: Triangulation in action. Administrative Science Quarterly, 24: 602–611. CrossRef
Kalorama. 2006. The worldwide market for in vitro diagnostic tests, 5th ed. New York: Market Research.
Lau, C. M., & Bruton, G. D. 2008. FDI in China: What we know and what we need to study next. Academy of Management Perspectives, 22(4): 30–44.
Lu, Y., Tsang, E. W. K., & Peng, M. W. 2008. Knowledge management and innovation strategy in the Asia Pacific: Toward an institution-based view. Asia Pacific Journal of Management, 25: 361–374. CrossRef
Makadok, R. 2001. Toward a synthesis of the resource-based and dynamic-capability views of rent creation. Strategic Management Journal, 22: 387–401. CrossRef
Martino, M. 2006. Economic development: Malaysia plays catch-up for biotech business. Fierce biotech. http://www.fiercebiotech.com, Accessed Dec. 15, 2008.
Meyer, K. E., Estrin, S., Bhaumik, S. K., & Peng, M. W. 2009. Institutions, resources, and entry strategies in emerging economies. Strategic Management Journal, 30: 61–80. CrossRef
MIDA (Malaysian Industrial Development Authority). 2008. Economic strength. http://www.mida.gov.my, Accessed Dec. 12, 2008.
Munroe, T., Craft, G., & Hutton, D. 2002. A critical analysis of the local biotechnology industry cluster—counties of Alameda, Contra Costa, & Solano in California. Research monograph prepared for the consortium of Bay Area organizations. http://www.baybio.org, Accessed May 2, 2002.
Peng, M. W. 2006. Global strategy. Mason: South-Western Thomson.
Peng, M. W., Wang, D. Y., & Jiang, Y. 2008. An institution-based view of international business strategy: A focus on emerging economies. Journal of International Business Studies, 39: 920–936. CrossRef
Peng, M. W., Sun, S. L., Pinkham, B., & Chen, H. 2009. The institution-based view as a third leg for a strategy tripod. Academy of Management Perspectives, (in press).
PerkinElmer. 2008. http://www.perkinelmer.com, Accessed Dec. 4, 2008.
Pisano, G. 2006. Can science be a business?. Harvard Business Review, 84(10): 114.
Porter, M. 1990. Competitive advantage of nations. New York: Free Press.
Porter, M. 1996. What is strategy?. Harvard Business Review, 74(6): 61–78.
Porter, M. 1998. Clusters and the new economics of competition. Harvard Business Review, 76(12): 78–90.
Priem, R. L., & Butler, J. E. 2001. Is the resource-based “view” a useful perspective for strategic management research?. Academy of Management Review, 26(1): 22–40. CrossRef
Ritchie, B. K. 2009. Economic upgrading in a state-coordinated, liberal market economy. Asia Pacific Journal of Management, 26. doi: 10.1007/s10490-008-9089-0.
Ross, J. 2004. Biotechnology growth takes time. http://www.marshall.edu, Accessed Nov. 14, 2007.
Sackett, P. R., & Larson, J. Jr. 1990. Research strategies and tactics in industrial and organization psychology. In M. D. Dunnette & L. M. Hough (Eds.). Handbook of industrial and organizational psychology: 419–489. Palo Alto: Consulting Psychologists Press.
Scandura, T. A., & Williams, E. A. 2000. Research methodology in management: Current practices, trends, and implications for future research. Academy of Management Journal, 43(6): 1248–1264. CrossRef
Steier, L. P. 2009. Familial capitalism in global institutional contexts: Implications for corporate governance and entrepreneurship in East Asia. Asia Pacific Journal of Management, 26. doi: 10.1007/s10490-008-9117-0.
StemLife. 2008. http://www.stemlife.com, Accessed Dec. 6, 2008.
Stuart, T., & Sorenson, O. 2003. The geography of opportunity: Spatial heterogeneity in founding rates and the performance of biotechnology firms. Research Policy, 32(2): 229–253. CrossRef
Su, Y.-S., Tsang, E. W. K., & Peng, M. W. 2009. How do internal capabilities and external partnerships affect innovativeness?. Asia Pacific Journal of Management, 26: 309–331. CrossRef
Tipton, F. B. 2009. Southeast Asian capitalism: History, institutions, states, and firms. Asia Pacific Journal of Management, 26. doi: 10.1007/s10490-008-9118-z.
Van de Ven, A. H., Polley, D. E., Gardud, R., & Venkataraman, S. 1999. The innovation journey. Oxford: Oxford University Press.
World Bank. 2008. http://www.worldbank.org, Accessed Dec. 2, 2008.
Yin, R. K. 1984. Case study research: Design and methods. Beverly Hills: Sage.
Zeller, C. 2001. Clustering biotech: A recipe for success? Spatial patterns of growth of biotechnology in Munich, Rhineland, and Hamburg. Small Business Economics, 17: 123–141. CrossRef
Zhou, L., Wu, W., & Luo, X. 2007. Internationalization and the performance of born-global SMEs: The mediating role of social networks. Journal of International Business Studies, 38: 673–690. CrossRef
- Resource-based and institution-based approaches to biotechnology industry development in Malaysia
Mark J. Ahn
Anne S. York
- Springer US
Neuer Inhalt/© Stellmach, Neuer Inhalt/© BBL, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta, Neuer Inhalt/© hww, Voraussetzungen für wirtschaftliche additive Fertigung/© Marco2811 | Fotolia